Food and Drug Administration

Roche Buys Flatiron in $1.9B ‘Big Data’ Move
Technology

Roche Buys Flatiron in $1.9B ‘Big Data’ Move

The real-world evidence Flatiron's record system collects "is a key ingredient to accelerate the development of, and access to, new cancer treatments."
By Matthew Heller | February 15, 2018
Read More
Hedge Fund Manager Accused of Insider Trading
Regulation

Hedge Fund Manager Accused of Insider Trading

The manager traded in advance of FDA announcements approving the sale of generic drugs.
By Matthew Heller | June 16, 2016
Read More
SEC Fines Research Firm $375K Over Compliance
Risk & Compliance

SEC Fines Research Firm $375K Over Compliance

Regulators say Marwood Group passed information that was "ripe for insider trading" to clients without vetting from its compliance department.
By Matthew Heller | November 30, 2015
Read More
The Whistleblower’s Trilemma
Risk Management

The Whistleblower’s Trilemma

Revealing company fraud or misconduct to regulators first is not always the best choice — if an employee chooses to blow the whistle at all.
By Marielle Segarra | March 28, 2014
Read More